The emerging role of epigenetic therapeutics in immuno-oncology
MJ Topper, M Vaz, KA Marrone, JR Brahmer… - Nature Reviews …, 2020 - nature.com
… targeting of DNA methylation and/or histone deacetylation (or acetylation), as extensively
reviewed elsewhere 104,110,111 , is a major focus of epigenetic therapy and is central to its …
reviewed elsewhere 104,110,111 , is a major focus of epigenetic therapy and is central to its …
[HTML][HTML] Mitoepigenetics and its emerging roles in cancer
Z Dong, L Pu, H Cui - Frontiers in cell and developmental biology, 2020 - frontiersin.org
… on mitoepigenetics and its roles in cancers, so as to provide a new sight for the diagnosis and
treatment of these disorders. … However, DNA methyltransferases seem to contribute to CpG …
treatment of these disorders. … However, DNA methyltransferases seem to contribute to CpG …
Epigenetic therapy in immune-oncology
PA Jones, H Ohtani, A Chakravarthy… - … Reviews Cancer, 2019 - nature.com
… Indeed, we have found that DNA methylation inhibitors work more effectively following
knockdown of some histone-modifying enzymes 37 . Another issue, which needs to be fully …
knockdown of some histone-modifying enzymes 37 . Another issue, which needs to be fully …
Epigenetic therapies for cancer
SE Bates - New England Journal of Medicine, 2020 - Mass Medical Soc
… and histone proteins are modified in ways that regulate accessibility and function, and an …
one hallmark of cancer. Epigenetic therapies seek to normalize DNA methylation patterns and …
one hallmark of cancer. Epigenetic therapies seek to normalize DNA methylation patterns and …
The emerging roles and therapeutic implications of epigenetic modifications in ovarian cancer
… epigenetic regulation of OC drug resistance and propose the potential clinical implications
of epigenetic therapies … reversing histone modifications and DNA methylation or by targeting …
of epigenetic therapies … reversing histone modifications and DNA methylation or by targeting …
The emerging role of epigenetics in human autoimmune disorders
… DNA methylation is one of the most studied epigenetic marks and typically occurs at the
pyrimidine C5 position of cytosine residues by transferring a methyl group from S-adenosyl-l-…
pyrimidine C5 position of cytosine residues by transferring a methyl group from S-adenosyl-l-…
DNA methyltransferases: emerging targets for the discovery of inhibitors as potent anticancer drugs
J Yu, T Xie, Z Wang, X Wang, S Zeng, Y Kang… - Drug Discovery …, 2019 - Elsevier
… with crucial roles in epigenetic regulation. They have been considered as promising
therapeutic targets for the epigenetic treatment of cancer. Therefore, DNMT inhibitors (DNMTis) …
therapeutic targets for the epigenetic treatment of cancer. Therefore, DNMT inhibitors (DNMTis) …
The promise for histone methyltransferase inhibitors for epigenetic therapy in clinical oncology: a narrative review
… (DNMTs) to specific genomic loci to promote DNA methylation [19,20,21]. On the … DNA
methylation and histone modification machinery critical for maintaining the cellular epigenetic …
methylation and histone modification machinery critical for maintaining the cellular epigenetic …
Epigenetic therapy for ovarian cancer: promise and progress
S Moufarrij, M Dandapani, E Arthofer, S Gomez… - … epigenetics, 2019 - Springer
… epigenetic abnormalities in ovarian cancer, discuss key scientific advances using epigenetic
therapies in preclinical ovarian cancer models… The epigenetic modification DNA methylation …
therapies in preclinical ovarian cancer models… The epigenetic modification DNA methylation …
DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application
C Hu, X Liu, Y Zeng, J Liu, F Wu - Clinical Epigenetics, 2021 - Springer
… between DNMT inhibitors and chemotherapeutic drugs make combining epigenetic therapy
and … Moreover, DNMT inhibitors can reverse epidermal growth factor (EGF) receptor (EGFR) …
and … Moreover, DNMT inhibitors can reverse epidermal growth factor (EGF) receptor (EGFR) …